Product pipeline
Development code number Class or application Developmental stage (1Q2006)
CS-747 (prasugrel) Oral antiplatelet agent Phase III
Colesevelam Diabetes (BAS) Phase III
CS-8663 Hypertension Phase III
CS-011 (rivoglitazone) Diabetes (PPAR) Phase II-III
DJ-927 Cancer chemotherapeutic (Taxane) Phase II
DU-176b Anticoagulant.(Factor Xa Inhibitor) Phase II
CS-3030 Anticoagulant.(Factor Xa Inhibitor) Phase I
DZ-697b Novel anti-platelet Phase I
CS-7017 Oncology (PPAR gamma) Phase I
CS-1008 Oncology (DR5) Phase I
CS-0777 Immunosuppressive Pre-clinical